2017-03-23,Versartis To Host Conference Call To Review Data From ENDO 2017 On Long-Acting Somavaratan For Growth Hormone Deficiency
2017-03-15,Versartis Appoints Tracy Woody As Chief Commercial Officer
2017-03-02,Versartis Announces Data On Long-Acting Somavaratan For Growth Hormone Deficiency To Be Featured In Late-Breaker Presentation At ENDO 2017
2017-03-01,Versartis To Present At Cowen & Co. Annual Healthcare Conference And Barclays Global Healthcare Conference
2017-02-21,Versartis Reports Fourth Quarter 2016 Financial Results
2017-02-15,Twitter Is One of Five Stocks Insiders Really Love Right Now
2017-01-31,Versartis Promotes Joshua T. Brumm To Chief Operating Officer And Paul Westberg To Chief Business Officer
2017-01-30,Versartis' Long-Acting Somavaratan For Growth Hormone Deficiency To Be Featured In Multiple Oral And Poster Presentations At ENDO 2017
2017-01-13,Versartis' Pipeline Holds Big Promise
2017-01-13,Versartis' Pipeline Holds Big Promise
2017-01-08,Don't Tell Anyone: Insiders Are Buying These Stocks Like Crazy
2016-12-01,Commit To Buy Versartis At $10, Earn 46.5% Annualized Using Options
2016-11-07,Versartis Presents Safety, Efficacy And IGF-I Data For Somavaratan In Pediatric Growth Hormone Deficiency At The 2016 Congress Of The GRS & IGF Society
2016-11-03,Versartis Reports Third Quarter 2016 Financial Results
2016-11-02,Versartis Enters Oversold Territory (VSAR)
2016-10-31,Versartis To Present At Two Investor Conferences In November
2016-10-04,Shark Bites: Versartis Is a Biotech Worth Tracking
2016-09-28,Versartis Announces Pricing Of Follow-On Offering
2016-09-27,Versartis Announces Proposed Offering Of Common Stock
2016-09-27,Short Interest Decreases By 26.6% For VSAR
2016-09-26,Versartis Initiates Phase 3 Trial Of Somavaratan In Japan For Children With Growth Hormone Deficiency Following Completion Of Phase 2
2016-09-12,Versartis Presents Data From Up To 30 Months Of Somavaratan Treatment For Pediatric Growth Hormone Deficiency At The 2016 ESPE Annual Meeting
2016-09-06,Versartis To Present At The Morgan Stanley Global Healthcare Conference
2016-09-06,Versartis To Host Investor Symposium Featuring Leading Experts In Growth Hormone Deficiency
2016-09-02,Versartis Presents Efficacy, Safety, Metabolic And Adherence Data For Somavaratan In Oral Session At The International Congress Of Endocrinology
2016-08-22,Versartis Announces Completion Of Enrollment In Phase 3 VELOCITY Trial Of Somavaratan In Pediatric GHD
2016-08-09,Teijin Limited And Versartis Enter Strategic Alliance For Commercialization Of Somavaratan Long-Acting Growth Hormone In Japan
2016-08-04,Versartis To Present At The Canaccord Genuity 36th Annual Growth Conference
2016-07-28,Versartis Reports Second Quarter 2016 Financial Results
2016-06-29,16 Biopharma Companies Besides Medivation That Are Attractive Targets
2016-04-28,Versartis Reports First Quarter 2016 Financial Results
2016-04-04,Versartis Presents Confirmatory Year Two Data From Ongoing Somavaratan Extension Study At Late-Breaker Session At ENDO Annual Meeting
2016-04-01,Versartis Presents Confirmatory 18-Month Adherence Data From Ongoing Somavaratan Extension Study At Late-Breaker Session At ENDO Annual Meeting
2016-03-30,Versartis Appoints Colin Hislop, M.D., As Chief Medical Officer
2016-03-20,8 Biotech Stocks Under $10 Making Big Moves Higher
2016-03-14,Versartis Announces Two Abstracts From Ongoing Pediatric Extension Study Of Somavaratan Selected For Late-Breaker Presentations At The Endocrine Society's 98th Annual Meeting
2016-03-08,RSI Alert: Versartis (VSAR) Now Oversold
2016-03-08,Capella Bioscience Completes Series A Financing Of £11 Million ($15.5 Million) To Progress Antibody Pipeline
2016-03-01,Versartis To Present At The Cowen And Company 36th Annual Health Care Conference
2016-02-18,Versartis Reports Fourth Quarter And Full Year 2015 Financial Results
2016-02-17,VSAR: Insiders vs. Shorts
2016-02-02,Versartis Reports Confirmatory Top-Line Two-Year Data From Ongoing Extension Study Of Somavaratan In GHD Children
2016-02-02,Medicxi Ventures, Formerly Index Ventures Life Sciences, Launches As An Independent Venture Capital Firm And Announces Closing Of A €210m Fund Including GSK And Johnson & Johnson Innovation
2016-01-28,Versartis To Host Conference Call To Review Two-Year Top-Line Data From Ongoing Extension Study Of Somavaratan
2015-12-16,Versartis' VRS-317 6-Month Data Published In The Journal Of Clinical Endocrinology & Metabolism
2015-11-16,VSAR: Insiders vs. Shorts
2015-11-03,Versartis To Present At The Credit Suisse 24th Annual Healthcare Conference
2015-10-29,Versartis Reports Third Quarter 2015 Financial Results
2015-10-01,Versartis Presents Confirmatory 18-Month Data From Ongoing Somavaratan Extension Study At Late-Breaker Session At ESPE Annual Meeting
2015-09-18,Versartis Announces Confirmatory 18-Month Data From Ongoing Extension Study Of Somavaratan In GHD Children
2015-09-10,Versartis Appoints Lars Ekman, MD, PhD, As Global Development Advisor
2015-09-10,Versartis Initiates Phase 2 Trial (VITAL) Of Monthly Somavaratan In Adults With Growth Hormone Deficiency
2015-09-08,Versartis Announces Agenda And Event Details For Investor Symposium Featuring Global Opinion Leaders In Pediatric Human Growth Hormone Deficiency (GHD)
2015-09-08,Versartis To Present At Upcoming Investor Conferences
2015-08-11,Versartis To Host Investor Symposium Featuring Global Opinion Leaders In Pediatric Human Growth Hormone Deficiency
2015-08-04,Versartis To Present At The Canaccord Genuity 35th Annual Growth Conference
2015-08-04,Versartis Abstract Accepted For Late-Breaker Presentation At The 54th Annual Meeting Of The European Society For Paediatric Endocrinology
2015-08-04,Versartis Reports Second Quarter 2015 Financial Results
2015-07-06,Versartis Price Gains on Drug Approval, eHealth Rises: Tech Winners & Losers
2015-07-06,Market News: Aetna, Versartis, Agile Therapeutics
2015-07-06,Versartis Announces Removal Of FDA Partial Clinical Hold And Continuation Of VRS-317 Phase 3 Clinical Trial
2015-07-01,10 Worst Biotech Stocks in the NASDAQ
2015-05-07,Versartis Becomes Oversold (VSAR)
2015-05-06,Versartis To Present At The Bank Of America Merrill Lynch 2015 Health Care Conference
2015-05-06,Versartis Provides Update On Clinical Programs And Reports First Quarter 2015 Financial Results
2015-05-06,Versartis Appoints Jay Shepard As President And Chief Executive Officer
2015-04-13,Versartis Initiates Phase 2/3 Trial Of VRS-317 In Japan For Children With Growth Hormone Deficiency
2015-03-06,Versartis Presents 12-Month Data For VRS-317 At Late-Breaker Session At Endocrine Society's Annual Meeting
2015-03-04,Versartis To Present At The Barclays Global Healthcare Conference
2015-02-23,Versartis To Present At The Cowen And Company 35th Annual Health Care Conference
2015-02-12,Versartis Reports Fourth Quarter And Full Year 2014 Financial Results
2015-02-02,Versartis To Present At The 2015 BIO CEO & Investor Conference
2015-01-21,Versartis Announces Pricing Of Follow-On Offering
2015-01-20,Versartis Announces Proposed Offering Of Common Stock
2015-01-08,Versartis Initiates Global Phase 3 Study Of VRS-317 In Children With Growth Hormone Deficiency
2015-01-05,Versartis Announces Positive 12 Month Data For VRS-317 From Ongoing Extension Study
2014-12-29,Versartis To Hold Conference Call To Discuss VRS-317 Clinical Update From Ongoing Extension Study
2014-11-24,Versartis To Present At The 26th Annual Piper Jaffray Health Care Conference
2014-11-06,Versartis Reports Third Quarter 2014 Financial Results
2014-11-06,Keith Lui Joins Versartis To Lead Global Marketing Efforts
2014-11-05,Versartis To Present At The 2014 Credit Suisse Healthcare Conference
2014-10-30,Versartis Schedules Conference Call To Discuss Plans For Phase 3 Trial For VRS-317 In Pediatric Growth Hormone Deficiency Patients
2014-09-02,Versartis To Present At The Morgan Stanley 2014 Global Healthcare Conference
2014-08-05,Versartis To Present At The Canaccord Genuity 34th Annual Growth Conference
2014-08-05,Versartis Reports Second Quarter 2014 Financial Results
2014-06-30,4 Stocks Rising on Unusual Volume
2014-03-21,Versartis (VSAR) Surges on First Trading Day
,
,
,
